Academic Journal

Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study

التفاصيل البيبلوغرافية
العنوان: Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study
المؤلفون: Nizar Mahlaoui, Fanny Fouyssac, Françoise Mazingue, Coralie Mallebranche, Malika Barthez-Toullec, Lamia Denti, Kalaivani Ruhier, Marie-Hélène André-Bonnet, Aude Marie-Cardine, Nathalie Aladjidi, Jean-Louis Stephan
المصدر: Frontiers in Pediatrics, Vol 11 (2023)
بيانات النشر: Frontiers Media S.A., 2023.
سنة النشر: 2023
المجموعة: LCC:Pediatrics
مصطلحات موضوعية: immunoglobulin, primary immunodeficiency, Clairyg®, post-approval safety study, real-world experience, pediatrics, Pediatrics, RJ1-570
الوصف: IntroductionThis study presents the results of a real-life, multicenter, prospective, post-approval safety evaluation of Clairyg® 50 mg/mL, a 5% intravenous immunoglobulin (IVIg) liquid, in 59 children (aged
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2296-2360
Relation: https://www.frontiersin.org/articles/10.3389/fped.2023.1260296/full; https://doaj.org/toc/2296-2360
DOI: 10.3389/fped.2023.1260296
URL الوصول: https://doaj.org/article/d8132084468e477497328dbe00d6d619
رقم الانضمام: edsdoj.8132084468e477497328dbe00d6d619
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:22962360
DOI:10.3389/fped.2023.1260296